187 related articles for article (PubMed ID: 31057992)
1. Primary Thyroid Lymphoma: An Analysis of the National Cancer Database.
Vardell Noble V; Ermann DA; Griffin EK; Silberstein PT
Cureus; 2019 Feb; 11(2):e4088. PubMed ID: 31057992
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases.
Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA
Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938
[TBL] [Abstract][Full Text] [Related]
3. Age related differences in primary testicular lymphoma: A population based cohort study.
Berjaoui MB; Herrera-Caceres JO; Li T; Qaoud Y; Tiwari R; Ma D; Khondker A; Naidu S; Ajaj R; Lajkosz K; Kenk M; Ajib K; Chandraseka T; Goldberg H; Fleshner N
Urol Oncol; 2023 Mar; 41(3):151.e1-151.e10. PubMed ID: 36702705
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.
Zhu Y; Yang S; He X
J Endocrinol Invest; 2022 Apr; 45(4):815-824. PubMed ID: 34865184
[TBL] [Abstract][Full Text] [Related]
5. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin Lymphoma: A Population-Based Study.
Singh V; Gor D; Gupta V; Jacob A; Du D; Eltoukhy H; Meghal T
World J Oncol; 2022 Aug; 13(4):159-171. PubMed ID: 36128593
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomogram and Competing Risk Analysis of Death for Primary Thyroid Lymphoma: A Long-term Survival Study of 1638 Patients.
Zhang K; Peng X; Wei T; Li Z; Zhu J; Chen YW
Ann Surg Open; 2022 Dec; 3(4):e226. PubMed ID: 36590887
[TBL] [Abstract][Full Text] [Related]
8. Association of Treatment Intensity With Survival in Older Patients With Hodgkin Lymphoma.
Rodday AM; Hahn T; Kumar AJ; Lindenauer PK; Friedberg JW; Evens AM; Parsons SK
JAMA Netw Open; 2021 Oct; 4(10):e2128373. PubMed ID: 34673965
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Indicators of Survival in Sinonasal Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis.
Brown HJ; Varelas EA; Ganti A; Papagiannopoulos P; Mark M; Kuan EC; Tajudeen BA
Laryngoscope; 2022 Aug; 132(8):1515-1522. PubMed ID: 34542177
[TBL] [Abstract][Full Text] [Related]
10. No difference in treatment outcome between patients with nodal versus extranodal diffuse large B-cell lymphoma.
Khan SR; Muhammad A; Soomar SM; Shoaib D; Arshad Ali A; Muhammad T; Zahir MN; Abdul Jabbar A; Abdul Rashid Y; Heger M; Moosajee MS
J Clin Transl Res; 2023 Feb; 9(1):37-49. PubMed ID: 36687299
[TBL] [Abstract][Full Text] [Related]
11. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M; Ross CW; Hsi ED
Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
[TBL] [Abstract][Full Text] [Related]
12. Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B-Cell Lymphoma.
Lehrich BM; Abiri A; Goshtasbi K; Birkenbeuel J; Yasaka TM; Papagiannopoulos P; Tajudeen BA; Brem EA; Kuan EC
Laryngoscope; 2021 Nov; 131(11):E2727-E2735. PubMed ID: 33899946
[TBL] [Abstract][Full Text] [Related]
13. Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma.
Gupta V; Singh V; Bajwa R; Meghal T; Sen S; Greenberg D; Anne M; Levitt MJ
J Hematol; 2022 Apr; 11(2):45-54. PubMed ID: 35573751
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
15. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
16. Primary thyroid lymphoma: A single-center experience.
Lee JS; Shin SJ; Yun HJ; Kim SM; Chang H; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2023; 14():1064050. PubMed ID: 36843586
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study.
Chai YJ; Hong JH; Koo do H; Yu HW; Lee JH; Kwon H; Kim SJ; Choi JY; Lee KE
Ann Surg Treat Res; 2015 Dec; 89(6):295-9. PubMed ID: 26665123
[TBL] [Abstract][Full Text] [Related]
18. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and prognostic factors for primary thyroid lymphoma: report on 28 Chinese patients and results of a population-based study.
Chen E; Wu Q; Jin Y; Jin W; Cai Y; Wang Q; Zhang X; Wang O; Li Q; Zheng Z
Cancer Manag Res; 2018; 10():4411-4419. PubMed ID: 30349374
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective analysis of 12 cases of primary thyroid lymphoma].
Zhang Y; Zhang JX; Shi J; Yu Y; Yuan ZF; Lu GZ; Gao Y; Gao YM; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):165-170. PubMed ID: 30773562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
